🌟 Australia Antacids Market Poised for Steady Growth with Expanding OTC Availability and Rising GERD Cases 🌟
According to Renub Research, the Australia Antacids Market is projected to grow from US$ 134.42 million in 2024 to US$ 180.51 million by 2033, registering a CAGR of 3.33% during the forecast period 2025–2033. This growth trajectory is primarily driven by the increasing prevalence of gastroesophageal reflux disease (GERD), lifestyle-related digestive issues, and the proliferation…